Managing patients with vulvovaginal candidiasis

Area of Science:

• Mycology
• Epidemiology
• Infectious Diseases

Background:

• Increasing prevalence of vulvovaginal candidiasis (VVC) reported in epidemiologic studies.
• Shift from Candida albicans to non-albicans Candida species, often less susceptible to standard antifungals.
• Growing need for effective VVC treatment strategies.

Purpose of the Study:

• To review the diagnosis and treatment of vulvovaginal candidiasis.
• To highlight the challenges posed by non-albicans Candida species.
• To emphasize patient compliance and modern therapeutic options.

Main Methods:

• Review of current epidemiologic data on VVC.
• Analysis of diagnostic approaches for VVC.
• Evaluation of therapeutic strategies, including topical and oral antifungals.
• Discussion of factors influencing treatment compliance.

Main Results:

• VVC prevalence is rising, with a notable increase in non-albicans Candida infections.
• Accurate diagnosis is essential for selecting appropriate antifungal therapy.
• Single-dose regimens and topical agents offer convenient and safe treatment options.
• Patient education and lifestyle-compatible regimens improve compliance.

Conclusions:

• Effective management of VVC requires accurate diagnosis and tailored treatment plans.
• Addressing the challenge of antifungal resistance is critical.
• Patient-centered approaches, including education and convenient regimens, enhance treatment success for vulvovaginal candidiasis.